Search PubMed⌕ Search

Biomedical subjects

C Zanussi

Publications and source records attributed to C Zanussi.

At least 163 records · Page 9Linked to original sources
PubMed1978

Acquired C1-inhibitor deficiency in essential cryoglobulinemia and macrocryoglobulinemia.

In 5 patients with mixed cryoglobulinemia, 3 with Waldenström's disease and 2 with essential cryoglobulinemia, a C1-inhibitor (C1-INH) deficiency was discovered. The complement profile was characteristic of the acquired type: the total hemolytic activity and the early components were reduced, C3 was diminished in 1 patient only, C5 and C9 were normal or elevated. 1 atient with Waldenström's disease and 1 with essential cryoglobulinemia experienced episodes of angioedema. Circulating immune complexes were found in all patients' sera by the 125I-radiolabelled C1q binding activity (C1q BA) test. The values of the C1q binding activity were correlated with the depletion of the early complement components and that of C1-inh. 4 patients showed circulating 7S IgM. Our data support the hypothesis of a complement activation by the cryoprecipitating immune complexes; the C1-INH depletion is secondary to its consumption following C1 activation.

Complement C1 Inactivator Proteins↗
PubMed1977

Effect of ageing on surface IgG of human peripheral lymphocytes.

An increase in the percentage of IgG bearing peripheral blood lymphocytes is observed in aged subjects as compared with young ones. Such a finding is probably due to the presence, in 'aged' sera, of a higher concentration of immune complexes, bound to lymphocytes through their Fc or Complement receptors.

Adult↗
PubMed1977

Anti-gamma-globulin activity, DNA and antibodies to DNA in nonlupoind cryoglobulinemias.

Anti-gamma-globulin activity, free DNA, and DNA binding were studied in 19 cryoglobulinemias: 8 patients with Waldenström's disease (WD), 9 patients with essential cryoglobulinemia (EC), and 2 with chronic aggressive hepatitis (CAH). Antihuman gamma-globulin activity was detected in all sera and dissolved cryoprecipitates but two from EC and one from the CAH group. By diphenylamine assay we found DNA in two sera from WD and in one serum and cryoprecipitate from EC. An antibody to denaturated DNA was shown only in sera from the two patients with CAH and from one patient with EC. Nonspecific binding was more frequent.

Antibodies, Anti-Idiotypic↗
PubMed1975

A study of complement functions in a family with hereditary angioneurotic edema.

A study of some complement functions was performed in two patients affected with hereditary angioneurotic edema (HAE) - mother and daughter - from a Southern Italy family (Apulia) and in three of their relatives. A decreased level of the C1 esterase plasma inhibitor was found in both the patients, who were treated with tranexamic acid with a slight, but definite improvement. However, the disease could not be traced beyond two generations in the pedigree and a couple of ascendants was found who were free from HAE both from the clinical standpoint and from that of the laboratory evaluation of complement functions. The possibility that HAE arose in the family through a mutational event is discussed.

Adolescent↗
PubMed1975

[Immune complexes DNA-anti-DNA during the course of mixed cryoglobulinemia].

Plasma and isolated cryoglobulins from ten patients with mixed cryoglobulinemia were studied for the presence of DNA using the diphenylamine reagent test. DNA-like material was detected in all the plasmas tested and it was also present in nine of the isolated cryoglobulins. IgM and IgG components of three cryoglobulins were purified by gel-filtration: anti-DNA activity was detected in IgG fraction (two cases), in IgM and IgG (one case); antigammaglobulin activity was always found in IgM fraction.

Antibodies, Anti-Idiotypic↗
PubMedDate not supplied

Functional characterization of specific IgE antibodies for tetanus toxoid.

The specific IgE response that appears in subjects immunized with tetanus toxoid does not induce hypersensitivity reactions at subsequent immunizations. The type I immune response, therefore, was studied both in vivo and in vitro, in 11 subjects who had specific IgE antibodies for tetanus toxoid. The results showed that: 1. the specific IgE antibodies are heterogeneous regarding their affinity for the mast cell and basophil receptors; 2. the specific IgG antibodies for tetanus toxoid, at serum concentrations, are not able to interfere with the in vitro specific basophil degranulation; 3. in the PEG precipitate there are aggregates of specific IgE antibodies for tetanus toxoid. In vitro, these molecular aggregates are not able to sensitize the basophil cells.

Adolescent↗
PubMedDate not supplied

The cryoglobulinemic syndrome.

The clinical and immunochemical classification of 376 patients with cryoglobulinemia is presented. In 141 cases (37.5%) the syndrome was considered idiopathic. Among the secondary forms, chronic liver diseases and connective tissue diseases shared most frequently mixed cryoglobulins (18.8 and 15.4% of cases, respectively). Another common association was that with Waldenström's macroglobulinemia: cryoglobulins were found in 20% of these patients. In 5 patients (2 with the essential form and 3 with cryoglobulinemia secondary to Waldenström's disease) a Cl-inhibitor deficiency was discovered; the complement profile was characteristic of the acquired type and episodes of angioedema occurred. Studying the clinical course of 71 cases of essential mixed cryoglobulinemia followed-up for 4-20 years we concluded that the evolution of type II and type III cryoglobulinemias is different because that of type II seems to have a more severe course and may differentiate in a lymphoproliferative disorder; the immunochemical type of cryoglobulins seems therefore to have a prognostic significance. Because of the considerable overlap in the distribution of immunochemical types among the clinical subsets, a mixed classification (both biochemical and clinical) is proposed.

Adult↗
PubMedDate not supplied

Hypergammaglobulinemic purpura of Waldenström. (A report of serologic and immunogenetic studies and long-term follow-up in 18 patients).

Data from a study carried out on a group of 18 patients with hypergammaglobulinemic purpura of Waldenström (HPW) followed-up for 3-14 years are reported in this paper. In 11 patients the syndrome was considered to be idiopathic, while in the remaining 7 it was associated with Sjögren's syndrome (SS). A marked (17/1) female prevalence was observed. Purpura was the presenting clinical manifestation in 9 patients, but it occurred at different points during the course of the disease; Raynaud's phenomenon was present in one third of patients. Serum gammaglobulin levels were higher than 2.2 g/dl in all the cases and higher than 3 g/dl in 9 cases. Immune complexes were detected in all patients. A significant serologic finding in our case series was represented by the frequency of anti-Ro (16/16) and anti-La (14/15) antibodies, clearly higher than that reported in SS patients. HLA typing showed a marked increase of B8 and DR3 antigens as well as A1,B8,DR3 haplotype, never reported in other autoimmune diseases. On the basis of serologic and immunogenetic features, HPW seems a clearly distinguishable entity among autoimmune vasculitis.

Adult↗
PubMedDate not supplied

Suppression of clonidine-induced release of growth hormone by thyrotropin releasing hormone in humans.

A single oral dose of clonidine (0.15 mg), a selective alpha-adrenergic stimulating agent, was able to increase plasma growth hormone (GH) levels (above 5 ng/ml) in 6 out of 7 normal men tested. This GH increase was independent of the hypotensive effect of the drug and was observed without any modification of plasma prolactin, thyroid stimulating hormone, gonadotropins and glycemia. When oral clonidine administration was associated to a slow thyrotropin releasing hormone (TRH) infusion (1 mg dissolved in 400 ml of 0.9% saline solution, at a constant rate during 150 min) the plasma GH response was significantly inhibited when compared with that observed after clonidine alone. These results suggest that in normal subjects TRH is capable of blocking the effect of an alpha-adrenergic stimulus which is conceivably acting at the level of central nervous system.

Adult↗
PubMedDate not supplied

Are double-blind food challenges necessary before starting an elimination diet?

Food allergy is normally treated by eliminating the offending food. Such a measure, however, may cause nutritional and sociopsychological problems, so an allergy must be diagnosed with the utmost certainty. To date the most reliable diagnostic test is the double-blind food challenge (DBFC). The rationale for using this test is the marked difference in positive results with open and double-blind food challenges. Only about 30% of open challenges that appear positive are confirmed on blind challenge. There is ample evidence, too, that a negative DBFC may in fact indicate tolerance to that food. From the literature it appears that almost all patients who reintroduced a certain food into their diet after a DBFC had given negative findings did not present any adverse reaction to it. In our caselist of 21 patients with probable reactions to foods but negative DBFC, 19 (90.5%) tolerated the "incriminated" food well when it was reintroduced into their diet even in unlimited amounts. Only two (9.5%) again presented symptoms when they started taking large amounts of the problem food. Therefore, one precaution recommended before reintroducing a food item into a patient's diet after a negative DBFC is to check how it is tolerated at high doses. A review of the literature confirms the unquestioned utility of the DBFC. Nevertheless, in some situations this test is not indicated. The main one, of course, is in patients with life-threatening symptoms such as anaphylactic shock or glottis edema, in whom any provocation test is contraindicated.(ABSTRACT TRUNCATED AT 250 WORDS)

Diet↗
PubMedDate not supplied

Resistance of beta-endorphin to dexamethasone inhibition in Parkinson's and Alzheimer's diseases.

The response of plasma beta-endorphin (beta-EP) to dexamethasone suppression was studied in 14 patients with Alzheimer's disease (AD), 14 patients with Parkinson's disease (PD), and 13 age-matched controls in order to evaluate whether an impairment of the opiate system is present in these neurodegenerative disorders. Basal circulating beta-EP was in normal range in all subjects, although the mean concentration was slightly reduced in the patients compared to controls. After 1 mg dexamethasone given at 11:00 p.m. the night before, plasma beta-EP concentration measured at 08:00 a.m. and 04:00 p.m. was not inhibited in AD and PD patients while it was significantly reduced in controls. Circulating ACTH and cortisol were similar in patients and controls and a normal inhibition of plasma cortisol after dexamethasone was observed in 13/14 AD and 12/14 PD patients. The resistance of beta-EP to dexamethasone inhibition is consistent with previous clinical and experimental data indicating a disorder of the opiate system in brain degenerative diseases.

Adrenocorticotropic Hormone↗